FHD-609
FHD-609-C-001
Phase 1 small_molecule terminated
Quick answer
FHD-609 for Advanced Synovial Sarcoma is a Phase 1 program (small_molecule) at Foghorn Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Foghorn Therapeutics
- Indication
- Advanced Synovial Sarcoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated